CCXI - ChemoCentryx, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5428.72M
Enterprise Value 3265.19M
Trailing P/E N/A
Forward P/E 1-5.71
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)12.68
Price/Book (mrq)5.99
Enterprise Value/Revenue 37.84
Enterprise Value/EBITDA 6-5.21

Trading Information

Stock Price History

Beta (3Y Monthly) 0.71
52-Week Change 3-38.64%
S&P500 52-Week Change 32.59%
52 Week High 314.98
52 Week Low 36.16
50-Day Moving Average 37.09
200-Day Moving Average 39.89

Share Statistics

Avg Vol (3 month) 3450k
Avg Vol (10 day) 3407.61k
Shares Outstanding 558.25M
Float 40.68M
% Held by Insiders 134.73%
% Held by Institutions 152.96%
Shares Short (Aug 15, 2019) 43.72M
Short Ratio (Aug 15, 2019) 49.19
Short % of Float (Aug 15, 2019) 48.42%
Short % of Shares Outstanding (Aug 15, 2019) 46.39%
Shares Short (prior month Jul 15, 2019) 44.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -144.27%
Operating Margin (ttm)-152.27%

Management Effectiveness

Return on Assets (ttm)-14.74%
Return on Equity (ttm)-97.20%

Income Statement

Revenue (ttm)33.81M
Revenue Per Share (ttm)0.64
Quarterly Revenue Growth (yoy)-52.30%
Gross Profit (ttm)-19.86M
EBITDA -50.92M
Net Income Avi to Common (ttm)-48.77M
Diluted EPS (ttm)-0.92
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)199.36M
Total Cash Per Share (mrq)3.42
Total Debt (mrq)22.42M
Total Debt/Equity (mrq)31.38
Current Ratio (mrq)3.57
Book Value Per Share (mrq)1.23

Cash Flow Statement

Operating Cash Flow (ttm)-66.02M
Levered Free Cash Flow (ttm)-34.61M